Suppr超能文献

一种用于定量检测头颈癌中表皮生长因子受体蛋白的灵敏酶联免疫吸附测定法:评估、解读及局限性

A sensitive enzyme-linked immunosorbent assay used for quantitation of epidermal growth factor receptor protein in head and neck carcinomas: evaluation, interpretations and limitations.

作者信息

Christensen M E, Engbaek F, Therkildsen M H, Bretlau P, Nexø E

机构信息

Department of Oto-Laryngology-Head and Neck Surgery, Rigshospitalet, University of Copenhagen, Denmark.

出版信息

Br J Cancer. 1995 Dec;72(6):1487-93. doi: 10.1038/bjc.1995.534.

Abstract

The EGF receptor is a transmembrane glycoprotein exerting mitogenic effects on epithelial cells. The purpose of the present study was to develop a sensitive enzyme-linked immunosorbent assay (ELISA) for determination of the epidermal growth factor receptor (EGFR) protein to examine whether the receptor was overexpressed in head and neck squamous cell carcinomas compared with the normal counterpart, and to establish whether clinicopathological correlations were present by investigating a broad spectrum of parameters (tumour size, clinical stage, positive lymph nodes, tumour site, histological grade, keratinisation, preoperative irradiation and clinical outcome). The assay employs two commercially available monoclonal antibodies, both detecting protein epitopes. The material comprises 60 head and neck carcinomas, corresponding normal tissue and normal oral mucosa from healthy individuals. The study demonstrates significantly higher receptor levels in tumours compared with normal tissue (P < 0.002) and a range in tumours and normal tissues of 0.4-10.5 and 0.1-4.3 nmol g-1 membrane protein respectively. Quantitation of receptors in normal mucosa emphasises the importance of using the patients' corresponding normal tissue, because using the patients' mucosa resulted in 83% overexpression, while using normal mucosa from healthy individuals only demonstrated overexpression in 50% of cases. No significant clinicopathological correlations could be established, although the mean values for EGFR increased with tumour size and advanced clinical stage. Furthermore, the prognostic value concerning disease-free survival, recurrence and the time interval for recurrence were investigated but no significance could be demonstrated. In conclusion, the investigation supports the theory of overexpression of EGFR protein as a common motif for malignant epithelial tumours, but limitations in interpretations are demonstrated and discussed further.

摘要

表皮生长因子受体是一种跨膜糖蛋白,对上皮细胞具有促有丝分裂作用。本研究的目的是开发一种灵敏的酶联免疫吸附测定法(ELISA)来测定表皮生长因子受体(EGFR)蛋白,以检查该受体在头颈部鳞状细胞癌中是否比正常对应组织过度表达,并通过研究一系列广泛的参数(肿瘤大小、临床分期、阳性淋巴结、肿瘤部位、组织学分级、角化、术前放疗和临床结果)来确定是否存在临床病理相关性。该测定法使用两种市售的单克隆抗体,二者均检测蛋白表位。材料包括60例头颈部癌、相应的正常组织以及健康个体的正常口腔黏膜。研究表明,与正常组织相比,肿瘤中的受体水平显著更高(P < 0.002),肿瘤和正常组织中受体水平的范围分别为0.4 - 10.5和0.1 - 4.3 nmol g-1膜蛋白。对正常黏膜中受体的定量强调了使用患者相应正常组织的重要性,因为使用患者的黏膜导致83%的过度表达,而使用健康个体的正常黏膜仅在50%的病例中显示过度表达。尽管EGFR的平均值随肿瘤大小和临床分期的进展而增加,但未能建立显著的临床病理相关性。此外,还研究了无病生存期、复发以及复发时间间隔的预后价值,但未显示出显著性。总之,该研究支持EGFR蛋白过度表达是恶性上皮肿瘤常见特征这一理论,但同时也展示并进一步讨论了解释方面的局限性。

相似文献

引用本文的文献

1
Oral field cancerization: an update on current concepts.口腔场癌化:当前概念的更新
Oncol Rev. 2014 Jun 30;8(1):244. doi: 10.4081/oncol.2014.244. eCollection 2014 Mar 17.
2
Oral field cancerization: current evidence and future perspectives.口腔场癌化:当前证据与未来展望
Oral Maxillofac Surg. 2012 Jun;16(2):171-80. doi: 10.1007/s10006-012-0317-x. Epub 2012 Feb 22.

本文引用的文献

3
Oncogenes in head and neck cancer.头颈癌中的癌基因
Laryngoscope. 1993 Jan;103(1 Pt 1):42-52. doi: 10.1288/00005537-199301000-00009.
4
Membrane-anchored growth factors.膜锚定生长因子
Annu Rev Biochem. 1993;62:515-41. doi: 10.1146/annurev.bi.62.070193.002503.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验